Cutting-edge research on the 30 most significant peptides in athletic performance, recovery, and luxury longevity science — curated for serious biohackers and longevity researchers.
Short-chain amino acid sequences that act as biological signaling molecules — directing cellular repair, hormonal release, and metabolic function with remarkable precision.
Unlike general supplements, peptides bind to specific receptors to trigger precise physiological responses — from growth hormone release to cellular repair cascades.
Many research peptides are bioidentical or analog versions of peptides your body already produces, often declining with age — making them a focus of longevity science.
The peptide space is one of the fastest-moving areas in biomedical research, with new studies emerging constantly across performance, cognition, and healthspan extension.
The most studied, most significant research peptides — organized by primary mechanism and application domain.
Pentadecapeptide derived from gastric juice with profound tissue repair properties. Extensive animal research shows accelerated tendon, muscle, and ligament healing.
Synthetic analog of the naturally occurring Thymosin Beta-4. Studied for its role in actin regulation, angiogenesis, and systemic tissue regeneration.
Extended half-life analog of IGF-1 with higher potency. Central to muscle cell differentiation, hypertrophy signaling, and satellite cell activation in skeletal muscle.
Produced locally in muscle tissue in response to mechanical damage. Activates satellite cells and initiates the repair and hypertrophy cascade post-exercise.
Hexapeptide ghrelin mimetic that stimulates pituitary GH release while increasing appetite — making it useful in wasting conditions and recovery protocols.
Second-generation GHRP with stronger GH release than GHRP-6 and minimal appetite stimulation. Widely studied in GH deficiency and age-related decline contexts.
Most potent of the first-generation GHRPs. Also demonstrates cardioprotective properties independent of GH release through direct cardiac receptor binding.
GHRH analog with extended half-life (days vs. minutes). When combined with DAC modification, produces sustained GH release — the cornerstone of modern GH peptide protocols.
Clean, selective ghrelin mimetic with no cortisol or prolactin elevation. Considered the gold standard GHRP for its purity of action and favorable safety profile in research.
The first 29 amino acids of endogenous GHRH. Stimulates the pituitary in a physiologic manner, making it the most conservative GHRH analog with a long clinical safety record.
Stabilized GHRH analog and the only FDA-approved growth hormone-releasing peptide. Demonstrated visceral fat reduction and improved body composition in clinical trials.
Telomerase activator developed by the St. Petersburg Institute of Bioregulation. Studied extensively for telomere lengthening, pineal gland regulation, and healthspan extension.
Naturally occurring copper-binding tripeptide with profound regenerative and anti-inflammatory properties. Activates over 4,000 human genes and plays a central role in skin, hair, and nerve repair.
Mitochondria-targeted antioxidant peptide that concentrates in inner mitochondrial membrane. Among the most promising peptides for age-related mitochondrial dysfunction.
Mitochondrially encoded peptide that functions as a metabolic regulator. Improves insulin sensitivity, exercise capacity, and has demonstrated lifespan extension in animal models.
First identified mitochondria-derived peptide. Demonstrates neuroprotective effects against Alzheimer's pathology, and inversely correlates with age and metabolic disease in humans.
Myostatin and activin inhibitor with dramatic effects on muscle mass ceiling. Among the most potent anabolic signals studied — animal research shows extreme hypertrophy potential.
Anxiolytic nootropic peptide developed by the Russian Academy of Sciences. Modulates BDNF expression and serotonin/dopamine metabolism — studied for anxiety, focus, and stress resilience.
ACTH-derived heptapeptide with significant BDNF and VEGF upregulation. Used clinically in Russia for stroke recovery and cognitive enhancement. One of the most studied nootropic peptides.
Orally active angiotensin IV analog estimated to be 10 million times more potent than BDNF at synaptogenesis. Studied for dementia and cognitive impairment — considered one of the most potent nootropics in research.
Once-weekly GLP-1 analog producing 15–20% body weight reduction in clinical trials. Demonstrated cardiovascular risk reduction and emerging research in neurological and longevity applications.
First-in-class dual GIP/GLP-1 receptor agonist. Produces superior weight loss outcomes vs. semaglutide alone — up to 22.5% body weight reduction in SURMOUNT trials.
C-terminal fragment of human growth hormone with isolated lipolytic activity. Stimulates fat burning without the growth-promoting or insulin-desensitizing effects of full hGH.
Nicotinamide N-methyltransferase (NNMT) inhibitor that elevates NAD+ and SAM levels. Reverses metabolic syndrome markers and reduces adipogenesis in preclinical research.
First-in-class triple agonist simultaneously targeting GLP-1, GIP, and glucagon receptors. Phase 2 trials showed up to 24.2% body weight reduction over 48 weeks — the highest reported for any weight-loss peptide to date. The glucagon component drives additional energy expenditure beyond dual agonists.
Naturally occurring thymic peptide and immune modulator. Clinically used in over 35 countries for hepatitis B/C, sepsis, and immune deficiency. Potent T-cell and NK cell activator.
The only member of the cathelicidin family in humans. Broad-spectrum antimicrobial, immunomodulatory, and wound-healing properties. Studied for chronic infections and inflammatory conditions.
Anti-inflammatory tripeptide derived from α-MSH. Powerfully suppresses NF-κB driven inflammation. Studied for IBD, skin inflammation, and as a gut-protective compound — notably effective orally.
Melanocortin receptor agonist acting centrally — not on vascular system — to enhance sexual arousal and function in both sexes. FDA-approved (Vyleesi) for HSDD in premenopausal women.
Cyclic analog of α-MSH with potent melanocortin activity. Studied for tanning, sexual function, appetite suppression, and neuroprotection — broader receptor activity than PT-141.
The most abundant intracellular peptide in mammalian cells. Central to actin dynamics, wound healing, and cardiac repair. TB-500 is a synthetic fragment — the full sequence offers additional systemic effects.
In a space filled with marketing noise, we prioritize what the actual science says.
Every compound profile is built from peer-reviewed literature, clinical trial data, and institutional research — not anecdote. We cite our sources so you can verify everything.
We cover the evidence that supports a compound and the evidence that doesn't. Risk profiles, limitations, and current regulatory status are included for every peptide.
The peptide research landscape moves fast. Our profiles are updated as new studies publish — subscribe to our research digest to receive new findings as they emerge.
We focus on compounds with the strongest signal-to-noise ratio for athletic performance, recovery optimization, and evidence-based longevity interventions.
Complex pharmacology translated into clear, usable research summaries. Protocol context, mechanism of action, and research application — without requiring a PhD to understand.
When we recommend research suppliers, it's based on independent quality standards — third-party testing, regulatory compliance, and sourcing transparency. No paid placements influence our editorial.
New compound profiles, landmark studies, and protocol updates delivered to your inbox. No filler, no spam — pure research signal.
Free forever · Unsubscribe anytime · No spam, ever